Establishmentof a strategy to regulate alloreactive T cells by CD14^+monocyte-derived endothelial-like cells for applying in organ transplantation
Establishmentof a strategy to regulate alloreactive T cells by CD14^+monocyte-derived endothelial-like cells for applying in organ transplantation
批准号:
20790931
负责人:
TANAKA Yuka
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009
中文摘要
我们已经建立了一种策略,通过使用来自外周血CD14+单核细胞的免疫调节内皮样细胞(ELCs),在没有非特异性免疫抑制剂的情况下抑制同种异体反应性T细胞。我们还试图建立一种体内小鼠模型来研究调节同种异体反应性T细胞的策略(即用同基因T细胞重建的肝内皮嵌合RAG-2/γ链双基因敲除小鼠)。从外周血CD14+单核细胞再生的ELCs表达MHCⅡ类分子、CD80和CD86以及T细胞抑制分子PDL-1和ILT-3。在混合反应培养体系中加入刺激型ELCs后,T细胞的增殖受到明显抑制,呈刺激物特异性。这些结果表明,在器官移植中,用供者外周血CD14+单核细胞再生的ELCs过继转移可以特异性地诱导同种异体反应性T细胞之间的耐受。
英文摘要
We have established a strategy to inhibit alloreactive T cells without nonspecific immunosuppressants by using immune-regulatory endothelial-like cells (ELCs) derived from peripheral blood CD14^+ monocytes. We have also attempted to establish an in vivo mouse model to investigate the strategy to regulate alloreactive T cells (i.e. liver endothelia-chimeric Rag-2/γ-chain double knockout mice reconstructed with syngeneic T cells). The ELCs regenerated from peripheral blood CD14+ monocytes expressed MHC class II, CD80 and CD86 together with PDL-1 and ILT-3 (inhibitory molecules against T cells). Adding the stimulator-type ELCs into the culture of mixed reaction assay resulted in the significant inhibition of T cell proliferation in the stimulator-specific fashion. These findings suggest that adoptive transfer with the ELCs regenerated from donor peripheral blood CD14^+ monocytes specifically induces tolerance among alloreactive T cells in organ transplantation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice.
胞苷单磷酸-N-乙酰神经氨酸羟化酶缺陷小鼠中针对 N-羟乙酰神经氨酸表位的抗体的免疫学特性。
DOI:
--
发表时间:
2009
期刊:
Journal of Immunology 184
影响因子:
--
作者:
[Tahara H, Ide K, Basnet N.B, Ohdan H, et al.]
通讯作者:
et al.
当院における肝移植後の免疫寛容をめざした試み~肝類洞内皮細胞の抗原特異的免疫寛容誘導能~
我院肝移植后实现免疫耐受的尝试-肝窦内皮细胞抗原特异性免疫耐受诱导能力-
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[Yuka Tanaka, Hirotaka Tashiro, Hideki Ohdan, 番匠谷将孝]
通讯作者:
番匠谷将孝
DOI:
10.1111/j.1399-3089.2010.00575.x
发表时间:
2010-05-01
期刊:
XENOTRANSPLANTATION
影响因子:
3.9
作者:
[Tahara, Hiroyuki, Ide, Kentaro, Ohdan, Hideki]
通讯作者:
Ohdan, Hideki
Optimization of immunosup pressive the rapy on the basis of immune monitoringby a multipara metric mixed lymphocy tereaction assay reduces in fectiouscomp lications and mortality inliving-donor liver transplantation
通过多参数混合淋巴细胞反应测定进行免疫监测,优化免疫抑制治疗可降低活体肝移植的感染性并发症和死亡率
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Yuka Tanaka, Hirotaka Tashiro, HidekiOhdan]
通讯作者:
HidekiOhdan
肝類洞内皮細胞の抗原特異的免疫寛容誘導能の解析
肝窦内皮细胞诱导抗原特异性免疫耐受能力分析
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[番匠谷将孝, 尾上隆司]
通讯作者:
尾上隆司
Analysis of association between allo-immune response and FOXP3 polymorphism in organ transplantation
-
批准号:15K10026
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2015
-
负责人:TANAKA Yuka
-
依托单位:
Generation of TRAIL positive NK cells from hematopoietic stem cells / iPS cells in vitro for anti-HCC immunotherapy
-
批准号:24591880
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:TANAKA Yuka
-
依托单位:
Investigation to determine a mechanism for T cell regulatory effects induced by treatment with high-dose immunoglobulin injection after organ transplantation.
-
批准号:22791253
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.5万
-
财政年份:2010
-
负责人:TANAKA Yuka
-
依托单位:
海外基金